NCT07883070 Study of Anxiety and Depression in Patients With Hematologic Malignancies
| NCT ID | NCT07883070 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Xiamen University |
| Condition | Hematologic Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-10-20 |
| Primary Completion | 2030-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-10-20 with a primary completion date of 2030-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies
Eligibility Criteria
Inclusion Criteria: 1. Patients with hematologic malignancies who visit the Department of Hematology at the First Affiliated Hospital of Xiamen University from August 2026 onward, including lymphoma, multiple myeloma, and leukemia. 2. Patients who are able to understand and voluntarily participate in anxiety and depression status assessments. Exclusion Criteria: 1\. Patients with any other conditions considered by the investigator to be inappropriate for participation in this study.
Contact & Investigator
Zhijuan Lin, Dr
PRINCIPAL INVESTIGATOR
The First Affiliated Hospital of Xiamen University
Frequently Asked Questions
Who can join the NCT07883070 clinical trial?
This trial is open to participants of all sexes, studying Hematologic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07883070 currently recruiting?
Yes, NCT07883070 is actively recruiting participants. Contact the research team at zjuan_lin@126.com for enrollment information.
Where is the NCT07883070 trial being conducted?
This trial is being conducted at Xiamen, China.
Who is sponsoring the NCT07883070 clinical trial?
NCT07883070 is sponsored by The First Affiliated Hospital of Xiamen University. The principal investigator is Zhijuan Lin, Dr at The First Affiliated Hospital of Xiamen University. The trial plans to enroll 100 participants.